Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Sinopharm Group Co., Ltd. Class H
1099Distribution services
$8.2B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Sinopharm Group Co., Ltd. Class H appears to be Failed.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)113.79%
Non-Shariah Cash Items
Cash And Cash Equivalents$54.3B
Other Short Term Investments$158K
Restricted Cash$12.8B
Liabilities (<30%)129.60%
Non-Shariah Liabilities
Current Capital Lease Obligation$1.8B
Long Term Debt$8.6B
Long Term Capital Lease Obligation$3.3B
Current Debt$62.7B
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
